Variant report
Variant | esv3340250 |
---|---|
Chromosome Location | chr14:55939252-55947823 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:55936925..55938790-chr14:55938821..55940391,2 | K562 | blood: | |
2 | chr14:55947632..55950014-chr14:55951455..55953042,2 | K562 | blood: | |
3 | chr14:55935959..55937646-chr14:55943697..55946148,2 | K562 | blood: | |
4 | chr14:55932703..55935495-chr14:55937792..55940291,2 | MCF-7 | breast: | |
5 | chr14:55946573..55948131-chr14:56047906..56049458,2 | K562 | blood: | |
6 | chr14:55934279..55936415-chr14:55944398..55946379,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs530386622 | chr14:55941072-55941073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs75719745 | chr14:55941129-55941130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs570500054 | chr14:55941160-55941161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs112486409 | chr14:55941174-55941175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs546824956 | chr14:55941185-55941186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs58452241 | chr14:55941195-55941196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs568292626 | chr14:55941253-55941254 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs535764638 | chr14:55941267-55941268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs144671032 | chr14:55941286-55941287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs147902540 | chr14:55941312-55941313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs539402686 | chr14:55941326-55941327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558125102 | chr14:55941336-55941337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs374970867 | chr14:55941417-55941418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs12432729 | chr14:55941431-55941432 | Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
15 | rs553228544 | chr14:55941447-55941448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs141586593 | chr14:55941456-55941457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs373141347 | chr14:55941478-55941479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533449620 | chr14:55941486-55941487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs546906171 | chr14:55941578-55941579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs57908495 | chr14:55941709-55941710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563530059 | chr14:55941741-55941742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200456753 | chr14:55941761-55941762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs545520645 | chr14:55941788-55941789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs59932390 | chr14:55941825-55941826 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs528202215 | chr14:55941902-55941903 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs546261293 | chr14:55941910-55941911 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs7155138 | chr14:55942032-55942033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs77842574 | chr14:55942069-55942070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190223131 | chr14:55942074-55942075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs182467193 | chr14:55942112-55942113 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs550863537 | chr14:55942116-55942117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs540913312 | chr14:55942139-55942140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs10137420 | chr14:55942264-55942265 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs7155545 | chr14:55942278-55942279 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs8017959 | chr14:55942310-55942311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs185222896 | chr14:55942353-55942354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs368260901 | chr14:55942381-55942382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs534304596 | chr14:55942405-55942406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs61976595 | chr14:55942423-55942424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs189691903 | chr14:55942424-55942425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs183878695 | chr14:55942435-55942436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs34772885 | chr14:55942443-55942444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs534321491 | chr14:55942481-55942482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs368638851 | chr14:55942489-55942490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs535695615 | chr14:55942500-55942501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs557108954 | chr14:55942594-55942595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs571046000 | chr14:55942602-55942603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12893080 | chr14:55942605-55942606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs12894333 | chr14:55942606-55942607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs372901308 | chr14:55942624-55942625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Breast cancer | 21633010 | CNVD |
Breast cancer | 22032731 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21364760 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Breast cancer | 17603634 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:55941000-55941800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr14:55941400-55941800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr14:55941600-55942000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr14:55941600-55942000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
5 | chr14:55941800-55943400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr14:55942000-55948400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr14:55942800-55943000 | Enhancers | Pancreas | Pancrea |
8 | chr14:55943000-55944000 | Weak transcription | Pancreas | Pancrea |
9 | chr14:55943400-55945400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr14:55943600-55945200 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
11 | chr14:55944000-55946200 | Enhancers | Pancreas | Pancrea |
12 | chr14:55944200-55944600 | Enhancers | Brain Hippocampus Middle | brain |
13 | chr14:55944200-55944800 | Enhancers | HSMMtube | muscle |
14 | chr14:55944400-55944800 | Enhancers | Adipose Nuclei | Adipose |
15 | chr14:55944400-55946000 | Enhancers | Left Ventricle | heart |
16 | chr14:55945400-55949600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |